Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

15.63
-0.1900-1.20%
Post-market: 15.800.1690+1.08%19:59 EST
Volume:25.35M
Turnover:399.65M
Market Cap:3.56B
PE:29.11
High:16.30
Open:15.65
Low:15.29
Close:15.82
52wk High:70.43
52wk Low:15.29
Shares:227.65M
Float Shares:197.51M
Volume Ratio:0.97
T/O Rate:12.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5369
EPS(LYR):0.5322
ROE:26.21%
ROA:5.54%
PB:6.12
PE(LYR):29.37

Loading ...

Earning Preview: Hims & Hers Health Inc. this quarter’s revenue is expected to increase by 31.66%, and institutional views are bearish

Earnings Agent
·
Feb 16

Mixed options sentiment in Hims and Hers Health with shares down 1.11%

TIPRANKS
·
5 hours ago

Ahead of Q4 Earnings, Let’s Look at Who Owns Hims & Hers Stock (HIMS)

TIPRANKS
·
5 hours ago

Dow Jones Top Company Headlines at 9 AM ET: Walmart Sales Climb, Driven by Grocery and Online Gains | Deere ...

Dow Jones
·
Feb 19

Stock Track | Hims & Hers Health Soars 9.22% Pre-Market on $1.15 Billion Eucalyptus Acquisition Deal

Stock Track
·
Feb 19

Hims & Hers Health to Acquire Australia's Eucalyptus for up to $1.15 Billion

Reuters
·
Feb 19

Hims & Hers Shares Extend Gains, Last up About 7.8%‍ Premarket

THOMSON REUTERS
·
Feb 19

Shares of Hims & Hers Rise 2.7% Premarket; Co to Acquire Eucalyptus in Deal Valued up to $1.15 Bln

THOMSON REUTERS
·
Feb 19

Hims & Hers to Acquire Eucalyptus for Up to $1.15 Billion

Reuters
·
Feb 19

Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform

THOMSON REUTERS
·
Feb 19

Hims & Hers Health Inc - $240 Mln USD Payable in Cash Upon Closing

THOMSON REUTERS
·
Feb 19

Hims & Hers: to Acquire Eucalyptus in Transaction Valued at up to $1.15 Bln

THOMSON REUTERS
·
Feb 19

Hims & Hers: Prepared to Finance Most of Deal With Cash on Hand & Future Operating Cash Flows From US Operations

THOMSON REUTERS
·
Feb 19

Hims & Hers: Consideration Includes Guaranteed Deferred Payments, Earnout Tied to Meeting Financial Targets Through Early 2029

THOMSON REUTERS
·
Feb 19

Hims & Hers: About $240 Mln Payable in Cash Upon Close

THOMSON REUTERS
·
Feb 19

Hims & Hers: Eucalyptus Brand Portfolio to Transition Into Hims & Hers Over Time

THOMSON REUTERS
·
Feb 19

Hims & Hers: Eucalyptus CEO Tim Doyle to Become Svp of International at Hims & Hers

THOMSON REUTERS
·
Feb 19

Is HIMS Stock a Buy Ahead of Earnings? Options Traders Brace for 17% Price Swing

TIPRANKS
·
Feb 19

FDA Moves to Restrict GLP-1 APIs Used in Compounded Drugs Sold by Hims & Hers

Reuters
·
Feb 18

Hims And Hers Faces GLP-1 Setback While Expanding Into Longevity Care

Simply Wall St.
·
Feb 18